Prostate CancerAI-CAPNCT07082049
AI-LLM Communication Aid in Prostate Cancer Care (AI-CAP)
A study testing Prostate surgery, LLM-assisted communication and Routine preoperative communication in people with Prostate Cancer, run by Fudan University at 1 site in China.
Trial summary
The goal of this clinical trial is to evaluate the efficacy of large language model (LLM)-assisted communication on psychological distress alleviation and healthcare efficiency improvement in prostate cancer patients. Read more about this study
- Who is it for?
- Ages 18 years and older, men only
- Conditions the study is for
- Prostate Cancer
- What is being tested?
- Prostate surgery, LLM-assisted communication and Routine preoperative communication
- Type of treatment
- Surgery or procedure, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 160 participants
- Where
- 1 siteChina
- Study dates
- 27 Jul 2025to 1 Jun 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Men only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Newly diagnosed prostate adenocarcinoma confirmed by histopathology;
- Age 18 years or older;
- Must be a candidate for radical prostatectomy, including but not limited to laparoscopic radical prostatectomy (LapRP) and robot-assisted radical prostatectomy (RARP);
- Ability to independently complete questionnaire filling and possess basic language comprehension ability;
- Ability to understand and willingness to sign informed consent.
Who cannot join
- A history of severe diagnosed mental illness (such as depression, anxiety disorder, insomnia);
- A history of diagnosed cognitive dysfunction (such as intellectual disability, Parkinson's disease);
- Requires emergency surgery (within 72 hours after diagnosis);
- Has participated in other interventional clinical trials.
Trial locations and contacts
1 site in 1 country.
China1 site
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032
About this study
Official title: A Randomized Controlled Trial on Artificial Intelligence-Powered Large Language Model-Assisted Doctor-Patient Preoperative Communication for Psychological Distress Alleviation and Healthcare Efficiency Improvement in Prostate Cancer Patients
The goal of this clinical trial is to evaluate the efficacy of large language model (LLM)-assisted communication on psychological distress alleviation and healthcare efficiency improvement in prostate cancer patients. The main questions it aims to answer are:
Does LLM-assisted communication reduce preoperative anxiety and negative emotion more effectively than standard care? Can LLM-assisted communication decrease clinician workload while maintaining communication quality?
Read more
Researchers will compare the intervention group (LLM-assisted communication) with the control group (standard communication) to see:
Whether LLM-assisted communication has greater reductions in patients' emotional distress scales and physiological stress metrics.
How it impacts clinician workload and communication time.
Participants will:
Undergo baseline assessments before communication, including a range of emotional scales and physiological metrics.
Receive clinician-reviewed LLM-generated materials and/or standard communication before surgery.
Complete assessments after preoperative communication.
- Conditions
- Prostate Cancer
- Being tested
- Prostate surgery, LLM-assisted communication, Routine preoperative communication
- Keywords
- prostate cancer, large language model, anxiety, patient distress, healthcare efficiency
- Medical subject headings
- Prostatic Neoplasms, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Prostate surgeryProcedure or surgery
Including but not limited to open radical prostatectomy, laparoscopic radical prostatectomy (LapRP) and robot-assisted radical prostatectomy (RARP).
LLM-assisted communicationBehavioural
Preoperatively, patients will communicate with the LLM, which will provide direct answers to their various questions, including but not limited to diagnosis, treatment options, operative risks, and complication management. To ensure the accuracy of LLM-generated responses in real-world clinical settings, all answers will undergo verification by the researchers before being provided to patients.
Routine preoperative communicationBehavioural
Preoperatively, patients will attend a consultation with the attending surgeon and surgical team. This physician-led communication will comprehensively discuss, current disease status, treatment options, operative risks, potential complication. The surgical team will subsequently address patient inquiries, followed by executing the informed consent form.
| Study group | Role | What they receive |
|---|---|---|
| LLM-assisted | Experimental | Patients will communicate with the LLM before surgery, which will provide answers based on their various concerns, including diagnosis, surgical plan selection, surgery risks, and handling of complications. Subsequently, patients will also continue to participate in the routine pre-operative communication held by surgeons. Receives: Procedure: Prostate surgery; Behavioral: LLM-assisted communication; Behavioral: Routine preoperative communication |
| Conventional routine communication | Experimental | Patients will participate routine pre-operative communication, held by the surgical team's lead physician, to inform the patient about the surgical plan selection, surgery risks, and the situation regarding post-operative complications, as well as to answer any patient inquiries. Receives: Procedure: Prostate surgery; Behavioral: Routine preoperative communication |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from Baseline in the GAD-7 score (Generalized Anxiety Disorder 7-item Scale) after the Preoperative Communication between Two Groups.
GAD-7 (Generalized Anxiety Disorder 7-item Scale) is a scale used to assess anxiety-related symptoms. Each of its 7 items is scored from a minimum of 0 to a maximum of 3 points, resulting in a total score ranging from 0 to 21. Higher scores indicate worse outcomes, as they reflect more severe anxiety symptoms.
Measured: At baseline and 24 hours after routine preoperative communication.
Difference of the NASA-TLX (NASA Task Load Index) between Two Groups
The NASA-TLX (NASA Task Load Index) is a widely used subjective assessment tool designed to measure perceivedworkload associated with performing a task. It evaluates six dimensions of workload: Mental Demand (cognitiveeffort), Physical Demand (physical effort), Temporal Demand (time pressure), Performance (self-rated task success),Effort (amount of work invested), and Frustration Level (stress or irritation).
Each dimension is rated by the participant on a 0-20 scale (0 = "very low" to 20 = "very high"). These ratings arecombined to generate an overall workload score, which ranges from 0 (minimum, indicating negligible workload) to120 (maximum, indicating extreme workload).
Higher scores on the NASA-TLX mean worse outcomes, as they reflect greater perceived task difficulty,cognitive/physical strain, or stress associated with the task.
Measured: 1 hour after routine preoperativecommunication.
Secondary outcomes (13)
Change from Baseline in the VAS-A (Visual Analogue Scale-Anxiety) after the Preoperative Communication between Two Groups.
The VAS-A (Visual Analogue Scale for Anxiety) is a simple scoring tool used to measure the severity of anxietysymptoms. It consists of a single 10-centimeter line with anchors at either end (e.g., "no anxiety" at 0 and "extremeanxiety" at 10). Patients mark a point on the line to indicate their current anxiety level, and the score is measured asthe distance from the "no anxiety" end. The minimum score is 0 (indicating no anxiety) and the maximum score is 10(indicating extreme anxiety). Higher scores mean worse outcomes, as they reflect more severe anxiety symptoms.
Measured: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the Heart Rate after the Preoperative Communication between Two Groups.
Heart rate is measured under resting conditions, with two times measured, and the average value is calculated. Heart rate (HR) is defined as the number of heartbeats per minute (bpm), higher HR may signal adverse reactions, or physiological stress.
Measured: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the Blood Pressure after the Preoperative Communication between Two Groups.
Blood pressure (BP) is recorded as two values: systolic blood pressure (SBP) and diastolic blood pressure (DBP). BP is measured under resting conditions, with two measurements taken, and the average value is calculated. Higher BP value may indicate a more tense state.
Measured: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the PSQ-18 ( Patient Satisfaction Questionnaire-18) after the Preoperative Communication between Two Groups.
The PSQ-18, or Patient Satisfaction Questionnaire-18, is a scale designed to assess patient satisfaction with healthcare services. It consists of 18 items, each rated on a 5-point Likert scale (1 = "very dissatisfied" to 5 = "very satisfied") to evaluate domains like communication, accessibility, and quality of care.
The total score ranges from 18 (minimum, indicating very low satisfaction) to 90 (maximum, indicating very high satisfaction).Higher scores on the PSQ-18 mean better outcomes, reflecting greater patient satisfaction with the healthcare experience.
Measured: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the EORTC QLQ-C30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30) after the Preoperative Communication between Two Groups.
The EORTC QLQ-C30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30) is a widely used self-report scale assessing health-related quality of life (HRQoL) in cancer patients. It comprises 30 items measuring three domains: functional scales (e.g., physical, role, emotional function), symptom scales (e.g., fatigue, pain, nausea), and a global health status/HRQoL scale.
Scores for each domain are linearly transformed to a range of 0 to 100. For functional scales and the global health status/HRQoL scale, higher scores indicate better outcomes (e.g., better physical function or overall quality of life).
For symptom scales, higher scores indicate worse outcomes (e.g., more severe fatigue or pain).
Measured: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the APAIS (Amsterdam Preoperative Anxiety and Information Scale) after the Preoperative Communication between Two Groups.
The APAIS (Amsterdam Preoperative Anxiety and Information Scale) is a tool designed to assess two key aspects of preoperative psychological state: anxiety related to surgery/anesthesia and the need for information about the procedure. It consists of 6 items, with 4 measuring anxiety (e.g., "I am worried about the anesthesia") and 2 assessing information needs (e.g., "I would like more information about what will happen during the operation"). Each item is rated on a 5-point Likert scale (1 = "not at all" to 5 = "extremely").
The total score ranges from 6 (minimum, indicating very low anxiety and minimal information needs) to 30 (maximum, indicating severe anxiety and strong information needs). Higher scores on the APAIS generally mean worse outcomes, as they reflect greater preoperative anxiety (a negative psychological state) and/or heightened unmet information needs.
Measured: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the B-IPQ-PCa (Brief Illness Perception Questionnaire for Prostate Cancer) after the Preoperative Communication between Two Groups.
The B-IPQ-PCa (Brief Illness Perception Questionnaire for Prostate Cancer) is a validated tool designed to assess prostate cancer patients' perceptions of their illness. It adapts the original Brief Illness Perception Questionnaire (B-IPQ) to focus on prostate cancer-specific experiences, measuring domains such as perceived illness timeline, consequences, personal/treatment control, identity (symptom burden), concern, emotional impact, and understanding of the illness.
The scale typically includes 8 scored items rated on 0-10 scale. Total scores range from 0 (minimum, reflecting more positive/adaptive illness perceptions) to 80 (maximum, indicating more negative/maladaptive perceptions).
Measured: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the PANAS score (Positive and Negative Affect Schedule) after the Preoperative Communication between Two Groups.
The Positive and Negative Affect Schedule (PANAS) is a widely used psychological tool to measure an individual's positive and negative emotional states. It consists of 20 items (10 for positive affect, 10 for negative affect), with each item rated on a 5-point scale (1 = "very slightly or not at all" to 5 = "extremely"). For each dimension: the minimum score is 10 (little to no affect) and the maximum score is 50 (intense affect). Higher scores on the Positive Affect (PA) subscale indicate better outcomes (e.g., greater enthusiasm, alertness, or joy), while higher scores on the Negative Affect (NA) subscale indicate worse outcomes (e.g., more distress, fear, or anger).
Measured: At baseline and 24 hours after routine preoperative communication.
Difference of Routine Preoperative Communication Time between Two Groups [minutes]
Duration of the routine preoperative communication, measured from the initiation of the discussion until the patient explicitly indicates no further questions, electronically timed and recorded in minutes.
Measured: At the routine preoperative communication.
Change from Baseline in the GAD-7 score (Generalized Anxiety Disorder 7-item Scale) after the LLM-assisted Preoperative Communication in LLM-assisted Group.
GAD-7 (Generalized Anxiety Disorder 7-item Scale) is a scale used to assess anxiety-related symptoms. Each of its 7 items is scored from a minimum of 0 to a maximum of 3 points, resulting in a total score ranging from 0 to 21. Higher scores indicate worse outcomes, as they reflect more severe anxiety symptoms.
Measured: At baseline and 24 hours after LLM-assisted preoperative communication.
Change from Baseline in the VAS-A (Visual Analogue Scale for Anxiety) Scale after the LLM-assisted Preoperative Communication in LLM-assisted Group.
The VAS-A (Visual Analogue Scale for Anxiety) is a simple scoring tool used to measure the severity of anxiety symptoms. It consists of a single 10-centimeter line with anchors at either end (e.g., "no anxiety" at 0 and "extreme anxiety" at 10). Patients mark a point on the line to indicate their current anxiety level, and the score is measured as the distance from the "no anxiety" end. The minimum score is 0 (indicating no anxiety) and the maximum score is 10 (indicating extreme anxiety). Higher scores mean worse outcomes, as they reflect more severe anxiety symptoms.
Measured: At baseline and 24 hours after LLM-assisted preoperative communication.
Change from Baseline in the MCMQ score (Medical Coping Modes Questionnaire) after the LLM-assisted Preoperative Communication in LLM-assisted Group.
The MCMQ score (Medical Coping Modes Questionnaire) is a scale designed to assess patients' coping strategies when facing illness. It typically consists of 20 items, with each item scored from 1 (least agreement) to 4 (most agreement), resulting in a total score ranging from 20 (minimum) to 80 (maximum). Higher scores alone do not universally indicate better or worse outcomes, as the scale measures three distinct coping dimensions: Confrontation (active engagement), Avoidance (distancing), and Resignation (passive acceptance). Higher scores on "Confrontation" often reflect more adaptive coping (better outcome), while higher scores on "Resignation" may indicate less adaptive coping (worse outcome).
Measured: At baseline and 24 hours after LLM-assisted preoperative communication.
Change from Baseline in the PANAS score (Positive and Negative Affect Schedule) after the LLM-assisted Preoperative Communication in LLM-assisted Group.
The Positive and Negative Affect Schedule (PANAS) is a widely used psychological tool to measure an individual's positive and negative emotional states. It consists of 20 items (10 for positive affect, 10 for negative affect), with each item rated on a 5-point scale (1 = "very slightly or not at all" to 5 = "extremely"). For each dimension: the minimum score is 10 (little to no affect) and the maximum score is 50 (intense affect). Higher scores on the Positive Affect (PA) subscale indicate better outcomes (e.g., greater enthusiasm, alertness, or joy), while higher scores on the Negative Affect (NA) subscale indicate worse outcomes (e.g., more distress, fear, or anger).
Measured: At baseline and 24 hours after LLM-assisted preoperative communication.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Jul 2025
- Study start27 Jul 2025
- Primary completion1 Jun 2027 (estimated)
- Study completion1 Jun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Prostate CancerStudies of the same condition, open and under way.
- More trials run by Fudan UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Care provider
- Enrolment
- 160 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fudan University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Bo Dai, Fudan University
- Investigators
- Bo Dai, MD, Principal investigator, Fudan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07082049
- Sponsor's protocol ID
- FUSCC-AI-CAP
- Acronym
- AI-CAP
- Status last verified
- Jul 2026
- First submitted
- 10 Jun 2025
- Last updated
- 7 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Controlled Trial on Artificial Intelligence-Powered Large Language Model-Assisted Doctor-Patient Preoperative Communication for Psychological Distress Alleviation and Healthcare Efficiency Improvement in Prostate Cancer Patients
- ClinicalTrials.gov ID
- NCT07082049
- Acronym / sponsor ID
- AI-CAP / FUSCC-AI-CAP
- Conditions
- Prostate Cancer
- Keywords
- prostate cancer, large language model, anxiety, patient distress, healthcare efficiency
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 160 participants (estimated)
- Lead sponsor
- Fudan UniversityUniversity, hospital or other
- Study start
- 27 Jul 2025 (actual)
- Primary completion
- 1 Jun 2027 (estimated)
- Study completion
- 1 Jun 2028 (estimated)
- First posted
- 24 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to evaluate the efficacy of large language model (LLM)-assisted communication on psychological distress alleviation and healthcare efficiency improvement in prostate cancer patients. The main questions it aims to answer are:
Does LLM-assisted communication reduce preoperative anxiety and negative emotion more effectively than standard care? Can LLM-assisted communication decrease clinician workload while maintaining communication quality?
Researchers will compare the intervention group (LLM-assisted communication) with the control group (standard communication) to see:
Whether LLM-assisted communication has greater reductions in patients' emotional distress scales and physiological stress metrics.
How it impacts clinician workload and communication time.
Participants will:
Undergo baseline assessments before communication, including a range of emotional scales and physiological metrics.
Receive clinician-reviewed LLM-generated materials and/or standard communication before surgery.
Complete assessments after preoperative communication.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (care provider)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| LLM-assisted | Experimental | Procedure: Prostate surgery, Behavioral: LLM-assisted communication, Behavioral: Routine preoperative communicationPatients will communicate with the LLM before surgery, which will provide answers based on their various concerns, including diagnosis, surgical plan selection, surgery risks, and handling of complications. Subsequently, patients will also continue to participate in the routine pre-operative communication held by surgeons. |
| Conventional routine communication | Experimental | Procedure: Prostate surgery, Behavioral: Routine preoperative communicationPatients will participate routine pre-operative communication, held by the surgical team's lead physician, to inform the patient about the surgical plan selection, surgery risks, and the situation regarding post-operative complications, as well as to answer any patient inquiries. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Newly diagnosed prostate adenocarcinoma confirmed by histopathology;
- Age 18 years or older;
- Must be a candidate for radical prostatectomy, including but not limited to laparoscopic radical prostatectomy (LapRP) and robot-assisted radical prostatectomy (RARP);
- Ability to independently complete questionnaire filling and possess basic language comprehension ability;
- Ability to understand and willingness to sign informed consent.
Key exclusion criteria (4 listed)
- A history of severe diagnosed mental illness (such as depression, anxiety disorder, insomnia);
- A history of diagnosed cognitive dysfunction (such as intellectual disability, Parkinson's disease);
- Requires emergency surgery (within 72 hours after diagnosis);
- Has participated in other interventional clinical trials.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Prostate surgeryIncluding but not limited to open radical prostatectomy, laparoscopic radical prostatectomy (LapRP) and robot-assisted radical prostatectomy (RARP). | Procedure or surgery | Conventional routine communication, LLM-assisted |
| LLM-assisted communicationPreoperatively, patients will communicate with the LLM, which will provide direct answers to their various questions, including but not limited to diagnosis, treatment options, operative risks, and complication management. To ensure the accuracy of LLM-generated responses in real-world clinical settings, all answers will undergo verification by the researchers before being provided to patients. | Behavioural | LLM-assisted |
| Routine preoperative communicationPreoperatively, patients will attend a consultation with the attending surgeon and surgical team. This physician-led communication will comprehensively discuss, current disease status, treatment options, operative risks, potential complication. The surgical team will subsequently address patient inquiries, followed by executing the informed consent form. | Behavioural | Conventional routine communication, LLM-assisted |
Primary outcome
Change from Baseline in the GAD-7 score (Generalized Anxiety Disorder 7-item Scale) after the Preoperative Communication between Two Groups.
Time frame: At baseline and 24 hours after routine preoperative communication.
GAD-7 (Generalized Anxiety Disorder 7-item Scale) is a scale used to assess anxiety-related symptoms. Each of its 7 items is scored from a minimum of 0 to a maximum of 3 points, resulting in a total score ranging from 0 to 21. Higher scores indicate worse outcomes, as they reflect more severe anxiety symptoms.
Difference of the NASA-TLX (NASA Task Load Index) between Two Groups
Time frame: 1 hour after routine preoperativecommunication.
The NASA-TLX (NASA Task Load Index) is a widely used subjective assessment tool designed to measure perceivedworkload associated with performing a task. It evaluates six dimensions of workload: Mental Demand (cognitiveeffort), Physical Demand (physical effort), Temporal Demand (time pressure), Performance (self-rated task success),Effort (amount of work invested), and Frustration Level (stress or irritation). Each dimension is rated by the participant on a 0-20 scale (0 = "very low" to 20 = "very high"). These ratings arecombined to generate an overall workload score, which ranges from 0 (minimum, indicating negligible workload) to120 (maximum, indicating extreme workload). Higher scores on the NASA-TLX mean worse outcomes, as they reflect greater perceived task difficulty,cognitive/physical strain, or stress associated with the task.
13 secondary outcomes
Change from Baseline in the VAS-A (Visual Analogue Scale-Anxiety) after the Preoperative Communication between Two Groups.
Time frame: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the Heart Rate after the Preoperative Communication between Two Groups.
Time frame: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the Blood Pressure after the Preoperative Communication between Two Groups.
Time frame: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the PSQ-18 ( Patient Satisfaction Questionnaire-18) after the Preoperative Communication between Two Groups.
Time frame: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the EORTC QLQ-C30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30) after the Preoperative Communication between Two Groups.
Time frame: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the APAIS (Amsterdam Preoperative Anxiety and Information Scale) after the Preoperative Communication between Two Groups.
Time frame: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the B-IPQ-PCa (Brief Illness Perception Questionnaire for Prostate Cancer) after the Preoperative Communication between Two Groups.
Time frame: At baseline and 24 hours after routine preoperative communication.
Change from Baseline in the PANAS score (Positive and Negative Affect Schedule) after the Preoperative Communication between Two Groups.
Time frame: At baseline and 24 hours after routine preoperative communication.
Difference of Routine Preoperative Communication Time between Two Groups [minutes]
Time frame: At the routine preoperative communication.
Change from Baseline in the GAD-7 score (Generalized Anxiety Disorder 7-item Scale) after the LLM-assisted Preoperative Communication in LLM-assisted Group.
Time frame: At baseline and 24 hours after LLM-assisted preoperative communication.
Change from Baseline in the VAS-A (Visual Analogue Scale for Anxiety) Scale after the LLM-assisted Preoperative Communication in LLM-assisted Group.
Time frame: At baseline and 24 hours after LLM-assisted preoperative communication.
Change from Baseline in the MCMQ score (Medical Coping Modes Questionnaire) after the LLM-assisted Preoperative Communication in LLM-assisted Group.
Time frame: At baseline and 24 hours after LLM-assisted preoperative communication.
Change from Baseline in the PANAS score (Positive and Negative Affect Schedule) after the LLM-assisted Preoperative Communication in LLM-assisted Group.
Time frame: At baseline and 24 hours after LLM-assisted preoperative communication.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jul 2026.
- Individual participant dataSharing planned: No
Related trials for Prostate Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
Active, not recruitingObservational study
MRI Fusion Biopsy vs. Micro-Ultrasound Guided Biopsy
Prostate Cancer
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Recruiting
Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
Prostate Cancer, Urinary Incontinence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Bo Dai, MD principal investigator
Fudan University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Prostate surgery, LLM-assisted communication and Routine preoperative communication in people with Prostate Cancer, run by Fudan University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from Baseline in the GAD-7 score (Generalized Anxiety Disorder 7-item Scale) after the Preoperative Communication between Two Groups. (time frame: At baseline and 24 hours after routine preoperative communication.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.